Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,363 | -49,434 | -45,901 | -128,821 | -90,238 |
| Depreciation Amortization | 1,086 | 957 | 942 | 3,784 | 3,082 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -2,246 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 4,081 | 686 |
| Other Working Capital | -1,678 | -799 | 866 | 2,307 | -2,643 |
| Other Operating Activity | 5,114 | 2,421 | 4,497 | 10,671 | 6,794 |
| Operating Cash Flow | $-60,841 | $-46,855 | $-39,596 | $-107,978 | $-84,565 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,536 | -633 | -1,066 | -11,609 | -7,551 |
| Purchase Of Investment | -208,465 | -160,123 | -42,598 | -382,025 | -152,713 |
| Sale Of Investment | 184,900 | 122,496 | 59,796 | 208,586 | 126,828 |
| Investing Cash Flow | $-26,101 | $-38,260 | $16,132 | $-185,048 | $-33,436 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 172 | 182 | 126 | 398,462 | 120,553 |
| Other Financing Activity | 89,651 | 97,715 | 0 | 0 | 0 |
| Financing Cash Flow | $89,823 | $97,897 | $126 | $398,462 | $120,553 |
| Beginning Cash Position | 24,266 | 11,484 | 34,822 | 42,661 | 40,109 |
| End Cash Position | 27,147 | 24,266 | 11,484 | 148,097 | 42,661 |
| Net Cash Flow | $2,881 | $12,782 | $-23,338 | $105,436 | $2,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,841 | -46,855 | -39,596 | -107,978 | -84,565 |
| Capital Expenditure | -2,536 | -633 | -1,066 | -11,609 | -7,551 |
| Free Cash Flow | -63,377 | -47,488 | -40,662 | -119,587 | -92,116 |